Perfil de pacientes com trombose venosa cerebral internados em um Hospital Universitário / Profile of patients with cerebral venous thrombosis hospitalized in a University Hospital

Objetivo: Caracterizar o perfil clínico e epidemiológico dos pacientes diagnosticados com trombose venosa cerebral em um Hospital Universitário de Teresina. Métodos: Trata-se de um estudo retrospectivo, transversal e descritivo, realizado através da avaliação de prontuários eletrônicos dos pacientes internados no Serviço de Neurologia de um Hospital Universitário de Teresina/PI, no período de maio a julho de 2021. Resultados: A amostra foi composta por 13 pacientes. A maioria era do sexo feminino (69,2%), com idade média de 39,2 anos. A cefaléia (92%) foi a manifestação clínica mais observada. O uso de contraceptivo oral foi o fator de risco mais associado à TVC, com 46%. A média de internação observada foi de 18,1 dias. Conclusão: Apesar de ser uma doença potencialmente grave, não foi observado óbito na população do estudo, que pode estar atrelado ao diagnóstico adequado e o tratamento em tempo hábil, capaz de refletir no êxito do desfecho de pacientes com TVC.

Objective: Characterize the clinical and epidemiological profile of patients diagnosed with cerebral venous thrombosis (CVT) in a University Hospital from Teresina. Methods: This is a retrospective, cross-sectional, and descriptive study, performed through the evaluation of electronic medical records of patients hospitalized in the Neurology Service of a University Hospital in Teresina/PI, from May to July 2021. Results: The sample consisted of 13 patients. The majority were female (69.2%), with an average age of 39.2 years. Cephalea (92%) was the most observed clinical manifestation. The use of oral contraceptives was the risk factor most associated with CVT, with 46%. The average of hospitalization observed was 18.1 days. Conclusion: Despite being a potentially serious disease, no death was observed in the study population, which may be tied to the appropriate diagnosis and timely treatment, capable of reflecting on the success of the outcome of patients with CVT.

Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A.

The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection.